Neurotech Investing and Partnering 2018 Recap
Dear Members of the Neurotech Community,
Thank you very much for taking the time to participate in the Neurotech Investing and Partnering Conference in Boston this May! Over 150 participants united in Boston including attendees and 70 speakers and panelists on the cutting edge of researching, developing and funding the next generation of treatments for the brain and nervous system.
Neurotech continues to be the premier business and investment conference for commercial neuroscience, including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference this year showcased how our community is focused on driving discovery of new treatments for the millions of patients that are afflicted by neurological and psychiatric diseases. This endeavor presents very unique challenges, with many failures and amazing successes that were all showcased through panel discussions and in depth company presentations.
The conference featured keynotes on the current state of the neurotech industry, cutting edge company presentations, leading translational research projects and interactive panel discussions which covered a comprehensive selection of neurotech topics. Our new and improved partnering system allowed attendees to find potential collaborators and request meetings to further their partnering and investment goals and drive their work forward.
The feedback we have received from many of you, thus far, has been quite positive. Please continue to share your ideas with us so we can make Neurotech even more useful and relevant for you.
We look forward to your joining us in May 21-22, 2019 in Boston.
Present your company’s device, drug, and/or therapy at next year’s event! For questions or suggestions about the conference and to submit a speaker proposal, contact the Neurotech team at email@example.com
Thank you for your continued support of the Neurotech Investing and Partnering Conference!
Carla Lema Tome
and the Neurotech 2018 team